Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)

Market Cap	7.97B
Revenue (ttm)	1.35B
Net Income (ttm)	113.29M
Shares Out	266.36M
EPS (ttm)	0.43
PE Ratio	60.84
Forward PE	41.26
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,498,300
Average Volume	3,480,746
Open	31.23
Previous Close	29.85
Day's Range	29.60 - 31.23
52-Week Range	26.61 - 56.77
Beta	-0.47
RSI	41.17
Earnings Date	Aug 29, 2025

About SHE:300049

Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. It operates in two segments, pharmaceutical production and sales; and diagnostic equipment R&D, production and sales. The pharmaceutical production and sales segment produces and sells products, such as Fufang Biejiaruangan tablets and shell fat capsules. The diagnostic equipment R&D, production and sales segment develops, produces, and sells the FibroScan series of liver fibrosis diagnostic instruments. It pro...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 703
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300049

Financial Performance

In 2024, SHE:300049's revenue was 1.35 billion, an increase of 16.93% compared to the previous year's 1.15 billion. Earnings were 113.29 million, an increase of 11.54%.